Head of Cancer Vaccine Development & Strategy

GlaxoSmithKline; Upper Providence (Delaware County); On-site; USD 341,000 - 568,000; Full time

Job summary

GlaxoSmithKline seeks a senior leader to oversee the global development of a cancer vaccine asset, coordinating across clinical, regulatory, manufacturing, and commercial functions. The role includes building the MDT and delivering the development strategy aligned with oncology objectives.

The position requires advanced oncology development experience, strategic vision, and ability to navigate diverse geographies, including potential UK/US operations and regulatory environments.

Qualifications

• Advanced degree including MD, PhD, PharmD, MBA, MS
• Oncology drug development expertise in global pharma/biotech
• Experience leading development and registration of medicines; cancer vaccines or IO

Responsibilities

• Act as single point of accountability for global cancer vaccine development across markets
• Build and lead the Medicine Development Team (MDT) across functions
• Deliver strategies to support regulatory approval, market access and lifecycle
• Oversee resource and budget planning for the asset
• Engage with regulators, payers, and academic/biotech collaborators

Skills

Business acumen

Clinical data interpretation

Clinical pharmacology

Clinical trial designs

Digital fluency

Drug development

Regulatory affairs

Evidence-based decision making

Executive presence

Hematology & Oncology

Leadership

Strategic direction

RWE & biomarker

Scientific presentations

Education

Advanced degree (MD/PhD/PharmD)

Tools

mRNA

Neoantigen-based platforms

Job description

GlaxoSmithKline seeks a senior leader to oversee the global development of a cancer vaccine asset, coordinating across clinical, regulatory, manufacturing, and commercial functions. The role includes building the MDT and delivering the development strategy aligned with oncology objectives.

The position requires advanced oncology development experience, strategic vision, and ability to navigate diverse geographies, including potential UK/US operations and regulatory environments.